Transplant Diagnostics Market to Attain a Valuation of USD 2.3 billion by 2031: Transparency Market Research Study

The market for transplant diagnostics is growing because of an increased emphasis on early profiling during organ transplantation and an increase in the prevalence of chronic renal illnesses.

WILMINGTON, Del., Jan. 3, 2024 /PRNewswire/ -- The global transplant diagnostics market was projected to attain US$ 1.2 billion in 2022. It is anticipated to garner a 7.7% CAGR from 2023 to 2031 and by 2031, the market is likely to attain US$ 2.3 billion by 2031.

Patients with chronic kidney disorders have a feasible and frequently chosen therapeutic option in transplantation. The worldwide transplant diagnostics market is expected to provide attractive prospects for research and development in noninvasive transplant diagnostic techniques, immunosuppressive drugs, and post-transplant care. Vendors are developing new tests and antigen products in order to broaden their range of offerings.

Request Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20225

Transplant Diagnostics Market Report Scope:

Key Findings of the Market Report 

• Organ harvesting is being encouraged by organizations all around the world, which is increasing the volume of organ donations.
• The technique known as Next Generation Sequencing (NGS) has greatly impacted organ transplantation.
• Human Leukocyte Antigens (HLA), which are essential for immune system compatibility, may be high-resolution typed using NGS.
• Transplant diagnostics market growth is anticipated to be constrained in the near future by the high prices of procedures including blood profiling, genomic profiling, and histocompatibility testing.
• The use of specialized molecular diagnostic platforms for these operations results in exorbitant expenses.
• Combining these technologies with conventional PCR/NGS equipment presents a number of difficulties.

Market Trends for Transplant Diagnostics

• The term "chronic kidney disease" refers to a degenerative illness that affects over 10% of people worldwide. Women, the elderly, and individuals with diabetes mellitus and hypertension are more likely to have the illness. Adversities associated with chronic renal illnesses necessitate creative approaches to improve care.
• When compared to long-term dialysis, kidney transplantation enhances quality of life. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), kidney failure affects 661,000 Americans. The market for transplant diagnostics is expanding due to the rise in chronic renal disease patients.
• The need for transplant diagnostics is increasing as early profiling during organ transplantation becomes more important. A thorough evaluation of several elements, such as genetic, molecular, and clinical indicators, is part of early profiling. It aids medical practitioners in creating transplant protocols and post-transplant care tailored to individual patients.

Global Market for Transplant Diagnostics: Regional Outlook

• In 2022, North America held the majority of the share. An increase in funding for organ transplant research and development is driving the dynamics of the regional market. The National Institutes of Health reports that 735 million US dollars would be spent on transplant research in 2022. Furthermore, according to the Organ Donation Statistics, the United States performed more than 40,000 organ transplants in 2021.
• The Europe transplant diagnostics market is expected to increase steadily throughout the course of the projected period, according to the most recent market projection. The market environment in Europe is being positively impacted by an increase in healthcare spending, the availability of more seamless applications for all transplantation procedures, and improved partnerships between donors and recipients.

Have Any Query? Ask Our Experts: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=20225

Global Transplant Diagnostics Market: Key Players

Leading companies in the transplant diagnostics industry are developing technologies that enable precise evaluations of organ compatibility. To improve pre-transplant testing, industry leaders such as Thermo Fisher Scientific, Illumina, and Bio-Rad Laboratories concentrate on advanced molecular and genomics solutions. They create technology for PCR, high-throughput sequencing, and HLA typing to guarantee accurate donor-recipient matching.

Their portfolios are strengthened by smart acquisitions and partnerships, which make complete transplant diagnostics services possible. By offering state-of-the-art diagnostic instruments and encouraging developments in tailored medicine for organ transplantation, these pioneers in the field want to raise the success rates of transplants. The following companies are well-known participants in the global transplant diagnostics market:

• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Becton, Dickinson, and Company
• Ortho Clinical Diagnostics
• Immucor Inc.
• Illumina Inc.
• Siemens Healthineers
• Agilent Technologies

Some of the key developments by the players in this market are:

• Beton, Dickinson and Company stated in February 2023 that the BD Onclarity HPV Assay was authorized by the US FDA to be used in combination with the ThinPrep Pap Test.
• The Food and Drug Administration of the United States approved Hologic's Aptima CMV Quant test in May 2022. This assay measures the cytomegalovirus (CMV) viral load in patients who have had solid organ or stem cell transplants.
• Luminex's single antigen product, LIFECODES LSATM Class I and Class II Assays, and MIA FORA NGS EXPRESS HLA Typing Software were the two additional products that Immucor Inc. introduced to their transplant diagnostics portfolio in March 2022.

Global Transplant Diagnostics Market Segmentation 

Screening

• Pre-transplant Diagnostics
• Post-transplant Diagnostics

Technique

• Molecular Assay
• Non-molecular Assay

Application

• Solid Organ Transplantation
  • Kidney
  • Liver
  • Heart
  • Lungs
  • Pancreas
  • Small Bowel
• Stem Cell Transplantation

Product & Services

• Reagents & Consumables
• Instruments
• Software & Services

End User

• Hospitals & Transplant Centers
• Research Laboratories
• Others

Region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=20225&ltype=S

More Trending Report by Transparency Market Research:

Acute Migraine Treatment Market- The global industry was valued at US$ 2.1 Bn in 2021. It is projected to advance at a CAGR of 15.1% from 2022 to 2031 and reach more than US$ 7.9 Bn by the end of 2031.

Dental Anesthetics Market- The global industry was valued at US$ 705.5 Mn in 2021. It is projected to grow at a CAGR of 2.6% from 2022 to 2031 and reach more than US$ 904.1 Mn by the end of 2031.

Fusion Inhibitors Market- The global industry was valued at US$ 295.3 Mn in 2021. It is projected to advance at a CAGR of 14.2% from 2022 to 2031 and reach more than US$ 7.2 Bn by 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn | Twitter | Blog | YouTube

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg